Alnylam Pharmace. buy WatchMen
Summary
This prediction ended on 09.02.20 with a price of €113.56. The BUY prediction by WatchMen for Alnylam Pharmace. saw massive gains of 54.50%. WatchMen has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alnylam Pharmace. | 0.174% | 0.174% | 32.184% | 60.615% |
iShares Core DAX® | 1.175% | -0.931% | 13.543% | 15.250% |
iShares Nasdaq 100 | 1.232% | 9.715% | 34.899% | 52.433% |
iShares Nikkei 225® | 1.563% | 3.040% | 8.943% | 6.828% |
iShares S&P 500 | 0.034% | 5.962% | 27.285% | 45.090% |
Comments by WatchMen for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.